Event on

Cardiovascular risk assessment and prevention: where do we stand?


Cardiac biomarkers and lipids might play a major role in the prevention of cardiovascular diseases.

Join this session to learn from experts in cardiovascular disease prevention about the recent evidence on risk stratification, to get insights from their daily clinical practice and to learn how to use cardiac biomarkers and lipid profile in a more efficient way.


  • Carolyn S. P. Lam

    Carolyn S. P. Lam
    (Singapore, SG)

    Welcome and Introduction


  • Naveed Sattar

    Naveed Sattar
    (Glasgow, UK)

    The role of troponins in primary prevention of CV events: Case report


  • Torbjørn Omland

    Torbjørn Omland
    (Oslo, NO)

    Practical recommendations for the management of patients with CV disease by using hsTnI


  • Gottfried Rudofsky

    Gottfried Rudofsky
    (Olten, CH)

    The confirmed role of LDL-cholesterol for the prevention and management of cardiovascular disease in patients with diabetes


제시된 견해와 의견은 저자의 것입니다. 이 웹캐스트에 포함된 콘텐츠는 정보 제공/교육 목적으로만 사용됩니다.

© 2023 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. Products available in select markets only. COL-00000